Dube Eric M
Known title: Chief Executive OfficerCIK: 0001763494
Associated companies
Transaction History
| TVTX | ▲ Buy | Option Exercise | 108,493 | $2.5M | 9/17/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 101,691 | $6.6M | 9/17/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 6,802 | $442K | 9/17/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 195,841 | $4.6M | 9/16/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 99,716 | $6.3M | 9/16/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 96,125 | $6.1M | 9/16/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 95,666 | $2.2M | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 63,498 | $3.9M | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 28,796 | $1.8M | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 3,102 | $197K | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 270 | $18K | 9/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 22,500 | $989K | 5/6/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 22,500 | $0 | 5/4/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 56,815 | $2.3M | 4/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 20 | $853 | 4/15/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 7,165 | $299K | 4/15/2026 | View on chart |
| TVTX | ▲ Buy | Grant | 64,000 | $0 | 4/13/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 34,902 | $1.1M | 4/1/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 25,098 | $790K | 4/1/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 60,000 | $928K | 4/1/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 60,000 | $928K | 2/20/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 60,000 | $1.8M | 2/20/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 66,452 | $2.1M | 2/3/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 33,635 | $1.1M | 2/3/2026 | View on chart |
| TVTX | ▲ Buy | Grant | 113,800 | $0 | 1/31/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 51,865 | $802K | 1/27/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 51,865 | $1.6M | 1/27/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 8,135 | $126K | 1/23/2026 | View on chart |
| TVTX | ▼ Sell | Open Market | 8,135 | $244K | 1/23/2026 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 27,128 | $419K | 10/29/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 27,128 | $817K | 10/29/2025 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 92,872 | $1.4M | 10/28/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 92,872 | $2.8M | 10/28/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 18,924 | $398K | 5/5/2025 | View on chart |
| TVTX | ▲ Buy | Option Exercise | 18,924 | — | 5/2/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 11,375 | $273K | 2/11/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 50,691 | $1.0M | 2/3/2025 | View on chart |
| TVTX | ▲ Buy | Grant | 130,000 | $0 | 1/31/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 10,736 | $209K | 1/22/2025 | View on chart |
| TVTX | ▼ Sell | Open Market | 21,125 | $243K | 9/9/2024 | View on chart |
| TVTX | ▲ Buy | Grant | 32,500 | $0 | 9/5/2024 | View on chart |
| TVTX | ▼ Sell | Open Market | 9,106 | $78K | 2/1/2024 | View on chart |
| TVTX | ▼ Sell | Open Market | 10,016 | $89K | 2/1/2024 | View on chart |
| TVTX | ▲ Buy | Grant | 135,000 | $0 | 1/31/2024 | View on chart |
| TVTX | ▼ Sell | Open Market | 7,873 | $71K | 1/23/2024 | View on chart |
| TVTX | ▼ Sell | Open Market | 4,455 | $66K | 9/5/2023 | View on chart |
| TVTX | ▲ Buy | Grant | 9,900 | $0 | 8/31/2023 | View on chart |
| TVTX | ▼ Sell | Open Market | 8,196 | $182K | 2/1/2023 | View on chart |
| TVTX | ▲ Buy | Grant | 97,500 | $0 | 1/31/2023 | View on chart |
| TVTX | ▼ Sell | Open Market | 6,442 | $139K | 1/24/2023 | View on chart |
| TVTX | ▼ Sell | Open Market | 5,625 | $117K | 1/5/2023 | View on chart |
| TVTX | ▼ Sell | Open Market | 4,832 | $135K | 2/10/2022 | View on chart |
| TVTX | ▲ Buy | Grant | 37,848 | $0 | 1/31/2022 | View on chart |
| TVTX | ▼ Sell | Open Market | 4,813 | $132K | 1/31/2022 | View on chart |
| TVTX | ▼ Sell | Open Market | 7,873 | $197K | 1/24/2022 | View on chart |
| TVTX | ▼ Sell | Open Market | 10,361 | $309K | 1/5/2022 | View on chart |
| TVTX | ▼ Sell | Open Market | 2,139 | $65K | 1/5/2022 | View on chart |
| TVTX | ▼ Sell | Open Market | 4,832 | $147K | 1/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Travere Shares Drop 6.7% Ahead of New FILSPARI Data
Travere Therapeutics shares fell 6.7% following the release of new data and a patent extension for its drug FILSPARI. The company is set to present results supporting FILSPARI as a foundational treatment for IgA Nephropathy and FSGS at the upcoming ASN Kidney Week 2026. These developments provide key context for investors evaluating the drug's long-term clinical value.
Travere Shares Drop 6.7% Ahead of New FILSPARI Data. Travere Therapeutics shares fell 6.7% following the release of new data and a patent extension for its drug FILSPARI. The company is set to present results supporting FILSPARI as a foundational treatment for IgA Nephropathy and FSGS at the upcoming ASN Kidney Week 2026. These developments provide key context for investors evaluating the drug's long-term clinical value.